Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Fabry disease: guidelines for the evaluation and management of multi-organ system involvement.

Eng CM, Germain DP, Banikazemi M, Warnock DG, Wanner C, Hopkin RJ, Bultas J, Lee P, Sims K, Brodie SE, Pastores GM, Strotmann JM, Wilcox WR.

Genet Med. 2006 Sep;8(9):539-48. Review.

PMID:
16980809
2.

[Fabry disease. An interdisciplinary challenge].

Cybulla M, Neumann HP.

Dtsch Med Wochenschr. 2007 Oct;132(43):2271-7. Review. German.

PMID:
17940933
3.

[Fabry disease: proposed guidelines from a French expert group for its diagnosis, treatment and follow-up].

Lidove O, Bekri S, Goizet C, Khau Van Kien A, Aractingi S, Knebelmann B, Choukroun G, Tsimaratos M, Redonnet-Vernhet I, Lacombe D, Jaussaud R.

Presse Med. 2007 Jul-Aug;36(7-8):1084-97. Epub 2007 Feb 2. Review. French.

PMID:
17276649
4.

[Neurological complications of Fabry-disease].

Vastagh I, Constantin T, Kéri A, Rudas G, Fekete G, Bereczki D.

Ideggyogy Sz. 2011 Jan 30;64(1-2):29-35. Review. Hungarian.

PMID:
21428036
5.

Anderson-Fabry disease: a multiorgan disease.

Tuttolomondo A, Pecoraro R, Simonetta I, Miceli S, Pinto A, Licata G.

Curr Pharm Des. 2013;19(33):5974-96. Review.

PMID:
23448451
6.
7.

Fabry disease.

Germain DP.

Orphanet J Rare Dis. 2010 Nov 22;5:30. doi: 10.1186/1750-1172-5-30. Review.

8.

Enzyme replacement therapy for Fabry disease, an inherited nephropathy.

Desnick RJ, Banikazemi M, Wasserstein M.

Clin Nephrol. 2002 Jan;57(1):1-8. Review.

PMID:
11837797
9.

Gastroenterological complications of Anderson-Fabry disease.

Buda P, Książyk J, Tylki-Szymanska A.

Curr Pharm Des. 2013;19(33):6009-13. Review.

PMID:
23448457
10.

Fabry disease: cardiac manifestations and therapeutic options.

Pierre-Louis B, Kumar A, Frishman WH.

Cardiol Rev. 2009 Jan-Feb;17(1):31-5. doi: 10.1097/CRD.0b013e31818adc50. Review.

PMID:
19092368
11.

Fabry nephropathy: a review - how can we optimize the management of Fabry nephropathy?

Waldek S, Feriozzi S.

BMC Nephrol. 2014 May 6;15:72. doi: 10.1186/1471-2369-15-72. Review.

12.

Effects of enzyme replacement therapy in Fabry disease--a comprehensive review of the medical literature.

Lidove O, West ML, Pintos-Morell G, Reisin R, Nicholls K, Figuera LE, Parini R, Carvalho LR, Kampmann C, Pastores GM, Mehta A.

Genet Med. 2010 Nov;12(11):668-79. doi: 10.1097/GIM.0b013e3181f13b75. Review.

PMID:
20962662
13.

Anderson-Fabry disease and the heart.

O'Mahony C, Elliott P.

Prog Cardiovasc Dis. 2010 Jan-Feb;52(4):326-35. doi: 10.1016/j.pcad.2009.11.002. Review.

PMID:
20109602
14.

Department-related tasks and organ-targeted therapy in Fabry disease: an interdisciplinary challenge.

Weidemann F, Sommer C, Duning T, Lanzl I, Möhrenschlager M, Naleschinski D, Arning K, Baron R, Niemann M, Breunig F, Schaefer R, Strotmann J, Wanner C.

Am J Med. 2010 Jul;123(7):658.e1-658.e10. doi: 10.1016/j.amjmed.2009.12.022. Review.

PMID:
20609689
15.

Renal complications of Fabry disease.

Basic-Jukic N, Kes P, Coric M, Basic-Kes V.

Curr Pharm Des. 2013;19(33):6046-50. Review.

PMID:
23448456
16.

[Current management of Fabry disease].

Cochat P, Liutkus A, Dubourg L, Levade T.

Nephrol Ther. 2006 Jan;2 Suppl 2:S167-71. Review. French.

PMID:
17373218
17.

Update on Fabry disease: kidney involvement, renal progression and enzyme replacement therapy.

Breunig F, Wanner C.

J Nephrol. 2008 Jan-Feb;21(1):32-7. Review.

PMID:
18264934
18.

[Anderson-Fabry disease].

Kes P, Basić-Jukić N, Brunetta B, Jurić I.

Acta Med Croatica. 2006;60(1):55-8. Review. Croatian.

PMID:
16802573
19.

Fabry disease: molecular genetics of the inherited nephropathy.

Desnick RJ, Astrin KH, Bishop DF.

Adv Nephrol Necker Hosp. 1989;18:113-27. Review.

PMID:
2564247
20.

The heart in Anderson Fabry disease.

Kampmann C, Wiethoff CM, Perrot A, Beck M, Dietz R, Osterziel KJ.

Z Kardiol. 2002 Oct;91(10):786-95. Review.

PMID:
12395219
Items per page

Supplemental Content

Write to the Help Desk